Business Context and Reporting Period
This Form 8-K Current Report was filed by Enochian Biosciences, Inc. (not Lunai Bioworks Inc.) on December 6, 2018, covering the event date of December 5, 2018. The registrant is a Delaware corporation with principal executive offices in Los Angeles, CA.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a corporate event rather than a financial statement.
Material Changes
- Nasdaq Listing Approval: On December 5, 2018, the company announced the approval of its application to list its common stock on the Nasdaq Capital Market.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, risk factors, or contingencies beyond the announcement of the listing approval. No unusual items were reported.
Investor Verification Checklist
- Verify the ticker symbol and trading status on the Nasdaq Capital Market effective December 5, 2018.
- Confirm the company name is Enochian Biosciences, Inc., as the input metadata referenced "Lunai Bioworks Inc."
- Review the attached Press Release (Exhibit 99.1) for specific details regarding the listing terms.